TRUALT — Trualt Bioenergy Balance Sheet
0.000.00%
- IN₹38.23bn
- IN₹50.34bn
- IN₹19.08bn
- 13
- 17
- 67
- 18
Annual balance sheet for Trualt Bioenergy, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 671 | 210 | 47.8 | 335 | 1,542 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 823 | 1,172 | 3,018 | 4,019 | 5,360 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,336 | 2,596 | 4,641 | 6,581 | 10,622 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,394 | 6,472 | 11,583 | 14,776 | 16,896 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,116 | 11,651 | 18,560 | 24,191 | 30,297 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,076 | 3,944 | 4,425 | 10,615 | 10,475 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5,395 | 10,554 | 16,155 | 21,545 | 22,607 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 721 | 1,097 | 2,405 | 2,646 | 7,690 |
| Total Liabilities & Shareholders' Equity | 6,116 | 11,651 | 18,560 | 24,191 | 30,297 |
| Total Common Shares Outstanding |